Filtricine provides new solution to cancer care via Targeted Nutrients Deprivation.
Filtricine's investors include True Ventures, SOSV, SOSV SF & NY (Fka IndieBio), Bluestein Ventures, Berkeley Catalyst Fund (BCF).
Filtricine is headquartered in Santa Clara, United States.
Filtricine provides new solution to cancer care via Targeted Nutrients Deprivation.
Filtricine is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Filtricine — Funding & Investors." VCBacked, August 29, 2022, https://www.vcbacked.co/company/filtricine. Accessed September 30, 2026.
VCBacked. (2022). Filtricine — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/filtricine
{{cite web |title=Filtricine — Funding & Investors |url=https://www.vcbacked.co/company/filtricine |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated